MANUFACTURING CAPABILITIES

UMEDICA remains committed to its focus of maintaining high quality standards & streamlining manufacturing procedures to ensure compliance with increasing stringent regulatory requirements. UMEDICA has a US FDA, EU, Health Canada, TGA, UAE MoH approved & WHO GMP approved manufacturing facility located in Vapi, Gujarat. The facility is equipped with world class machines capable of manufacturing a wide range of formulations - Injections, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA’s diverse product portfolio with a patient-centric approach comprises of antibiotics, anti-diabetics, anti-hyperlipidemic, anti-hypertensives, non-steroidal anti-inflammatory (NSAIDs), analgesics, antifungal, anti-malarial, antihistaminics, psychotropic, diuretics, anti-hypertensives, drugs for sexual dysfunction and multivitamins etc. UMEDICA has the expertise in manufacturing Sustained Release Formulations (Tablets & Capsules). The facility has been audited and approved by Regulatory authorities of various countries viz. USA, EU, Australia, Canada, UAE, Zimbabwe, Ethiopia, Tanzania, Nigeria, Uganda, Kenya, Ghana, Ivory Coast, Malawi etc.

QUALITY ASSURANCE & QUALITY CONTROL

UMEDICA undertakes and ensures quality assurance at each stage, right from raw materials receipt to finished products. Quality tests are carried out on all raw materials, excipients, packing materials, etc. to ensure highest international quality standards. UMEDICA’s facility is GLP (Good Laboratory Practices) compliant. Independent and well equipped QA & QC departments establish and maintain an effective quality control check to ensure that the final product is of a world-class standard. UMEDICA’s Quality Management Team ensures that every product manufactured and distributed complies with all internationally accepted good practices and standards of quality, purity, efficacy and safety.

RESEARCH & DEVELOPMENT

Umedica has a dedicated R&D centre with a built-up area of 19,000 sq. ft. located at Turbhe, Navi Mumbai. The R&D centre is approved by the Ministry of Science &Technology, Government of India and aims to shape, innovate and grow the organization globally in generics. The R&D centre is equipped with dedicated & experienced team of more than 90 scientists having diverse knowledge and expertise.